Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis

Daniela Lötsch, Elisabeth Steiner, Klaus Holzmann, Sabine Spiegl-Kreinecker, Christine Pirker, Juraj Hlavaty, Helga Petznek, Balazs Hegedus, Tamas Garay, Thomas Mohr, Wolfgang Sommergruber, Michael Grusch, Walter Berger

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Despite their ubiquitous expression and high conservation during evolution, precise cellular functions of vault ribonucleoparticles, mainly built of multiple major vault protein (MVP) copies, are still enigmatic. With regard to cancer, vaults were shown to be upregulated during drug resistance development as well as malignant transformation and progression. Such in a previous study we demonstrated that human astrocytic brain tumours including glioblastoma are generally high in vault levels while MVP expression in normal brain is comparably low. However a direct contribution to the malignant phenotype in general and that of glioblastoma in particular has not been established so far. Thus we address the questions whether MVP itself has a pro-tumorigenic function in glioblastoma. Based on a large tissue collection, we re-confirm strong MVP expression in gliomas as compared to healthy brain. Further, the impact of MVP on human glioblastoma aggressiveness was analysed by using gene transfection, siRNA knock-down and dominant-negative genetic approaches. Our results demonstrate that MVP/vaults significantly support migratory and invasive competence as well as starvation resistance of glioma cells in vitro and in vivo. The enhanced aggressiveness was based on MVP-mediated stabilization of the epidermal growth factor receptor (EGFR)/phosphatidyl-inositol-3-kinase (PI3K) signalling axis. Consequently, MVP overexpression resulted in enhanced growth and brain invasion in human glioblastoma xenograft models. Our study demonstrates, for the first time, that vaults have a tumour-promoting potential by stabilizing EGFR/PI3K-mediated migration and survival pathways in human glioblastoma.

Original languageEnglish
Pages (from-to)1904-1918
Number of pages15
JournalOncotarget
Volume4
Issue number11
Publication statusPublished - Nov 1 2013

Keywords

  • EGFR
  • Glioblastoma multiforme
  • Invasion
  • Major vault protein
  • PI3K

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis'. Together they form a unique fingerprint.

  • Cite this

    Lötsch, D., Steiner, E., Holzmann, K., Spiegl-Kreinecker, S., Pirker, C., Hlavaty, J., Petznek, H., Hegedus, B., Garay, T., Mohr, T., Sommergruber, W., Grusch, M., & Berger, W. (2013). Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis. Oncotarget, 4(11), 1904-1918.